Physiomics said it had successfully completed a UK grant project related to improving cancer treatments that received £131k of state funding.
The project, dubbed 'Decision Support System For Stratified Cancer Treatment' analysed data from over 400 oesophageal cancer patients to determine factors that could help guide treatment. It also created a tool for healthcare professionals to visualise the data.
'The results and learnings from the project have potential applications in both the company's existing business advising R&D based pharmaceutical and biotech companies as well as in the emerging field of personalised cancer treatment,' the company said.
'In order to further develop the technology the company is actively seeking additional grants in this space.'
At 9:31am: (LON:PYC) Physiomics PLC share price was +0.1p at 5.03p